Diamines & Chemicals Limited has submitted to the Exchange, the outcome of the Board Meeting dated February 12, 2026
DIAMINESQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 2.4 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Diamines & Chemicals reported its unaudited financial results for Q3 and nine months ended December 31, 2025. Revenue from operations fell sharply to ₹763.57 lakhs in Q3 FY26 from ₹930.43 lakhs a year ago, while 9M FY26 revenue plunged to ₹2,917.05 lakhs from ₹5,349.78 lakhs in 9M FY25, a roughly 45% year-on-year decline. The company swung to a 9M FY26 standalone loss of ₹901.97 lakhs, against a profit of ₹287.07 lakhs in the prior-year period, though the Q3 standalone loss narrowed to ₹191.45 lakhs from ₹370.44 lakhs. On a consolidated basis, the 9M FY26 net loss came in at ₹1,036.74 lakhs, with subsidiary DACL Fine Chem and associate KU Organic Diamines also reporting losses. The board also approved a revised Related Party Policy under the SEBI LODR Fifth Amendment, 2025, and made a ₹4.62 lakh provision for the new Labour Codes. Auditors KC Mehta & Co LLP issued a clean, unqualified limited review report.
Sharp revenue contraction and a return to losses point to significant business headwinds, which are likely to weigh negatively on the stock in the short term. The narrowing Q3 loss offers a small sign of stabilisation, but the full-year FY26 outlook remains weak unless the revenue recovery picks up.